David C Hsu1,2,3, Elizabeth C Mormino4, Aaron P Schultz4, Rebecca E Amariglio4,2, Nancy J Donovan1,2,5, Dorene M Rentz4,2,5, Keith A Johnson4,6,2, Reisa A Sperling4,2, Gad A Marshall4,2. 1. Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 2. Department of Neurology, Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 3. Department of Psychiatry, Mercy Medical Group, Sacramento, CA, USA. 4. Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 5. Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 6. Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Lower body-mass index (BMI) in late life has been associated with an increased risk of dementia, and weight loss has been associated with more rapid decline in Alzheimer's disease (AD) dementia. OBJECTIVE: To explore the association between BMI and cortical amyloid burden in clinically normal (CN) elderly at risk for AD dementia. METHODS: Cross-sectional analyses were completed using baseline data from the Harvard Aging Brain Study, consisting of 280 community-dwelling CN older adults aged 62-90. Assessments included medical histories and physical exam, Pittsburgh compound B (PiB) positron emission tomography (PET) amyloid imaging, and apolipoprotein E ɛ4 (APOE4) genotyping. For the primary analysis, a general linear regression model was used to evaluate the association of BMI with PiB retention. Covariates included age, sex, years of education, and APOE4 carrier status. Secondary analyses were performed for BMI subdivisions (normal, overweight, obese), APOE4 carriers, and BMI×APOE4 interaction. RESULTS: In the primary analysis, greater PiB retention was associated with lower BMI (β = -0.14, p = 0.02). In the secondary analyses, APOE4 carrier status (β= -0.27, p = 0.02) and normal BMI (β= -0.25, p = 0.01), as opposed to overweight or obese BMI, were associated with greater PiB retention. The BMI×APOE4 interaction was also significant (β= -0.14, p = 0.04). CONCLUSIONS: This finding offers new insight into the role of BMI at the preclinical stage of AD, wherein lower BMI late in life is associated with greater cortical amyloid burden. Future studies are needed to elucidate the mechanism behind this association, especially in those with lower BMI who are APOE4 carriers.
BACKGROUND: Lower body-mass index (BMI) in late life has been associated with an increased risk of dementia, and weight loss has been associated with more rapid decline in Alzheimer's disease (AD) dementia. OBJECTIVE: To explore the association between BMI and cortical amyloid burden in clinically normal (CN) elderly at risk for AD dementia. METHODS: Cross-sectional analyses were completed using baseline data from the Harvard Aging Brain Study, consisting of 280 community-dwelling CN older adults aged 62-90. Assessments included medical histories and physical exam, Pittsburgh compound B (PiB) positron emission tomography (PET) amyloid imaging, and apolipoprotein E ɛ4 (APOE4) genotyping. For the primary analysis, a general linear regression model was used to evaluate the association of BMI with PiB retention. Covariates included age, sex, years of education, and APOE4 carrier status. Secondary analyses were performed for BMI subdivisions (normal, overweight, obese), APOE4 carriers, and BMI×APOE4 interaction. RESULTS: In the primary analysis, greater PiB retention was associated with lower BMI (β = -0.14, p = 0.02). In the secondary analyses, APOE4 carrier status (β= -0.27, p = 0.02) and normal BMI (β= -0.25, p = 0.01), as opposed to overweight or obese BMI, were associated with greater PiB retention. The BMI×APOE4 interaction was also significant (β= -0.14, p = 0.04). CONCLUSIONS: This finding offers new insight into the role of BMI at the preclinical stage of AD, wherein lower BMI late in life is associated with greater cortical amyloid burden. Future studies are needed to elucidate the mechanism behind this association, especially in those with lower BMI who are APOE4 carriers.
Entities:
Keywords:
Alzheimer’s disease; Pittsburgh compound B; amyloid; apolipoprotein E; body mass index; clinically normal elderly; positron emission tomography
Authors: Stephanie Jb Vos; Chengjie Xiong; Pieter Jelle Visser; Mateusz S Jasielec; Jason Hassenstab; Elizabeth A Grant; Nigel J Cairns; John C Morris; David M Holtzman; Anne M Fagan Journal: Lancet Neurol Date: 2013-09-04 Impact factor: 44.182
Authors: Michael D Jensen; Donna H Ryan; Caroline M Apovian; Jamy D Ard; Anthony G Comuzzie; Karen A Donato; Frank B Hu; Van S Hubbard; John M Jakicic; Robert F Kushner; Catherine M Loria; Barbara E Millen; Cathy A Nonas; F Xavier Pi-Sunyer; June Stevens; Victor J Stevens; Thomas A Wadden; Bruce M Wolfe; Susan Z Yanovski; Harmon S Jordan; Karima A Kendall; Linda J Lux; Roycelynn Mentor-Marcel; Laura C Morgan; Michael G Trisolini; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli Journal: Circulation Date: 2013-11-12 Impact factor: 29.690
Authors: Ronald C Petersen; Heather J Wiste; Stephen D Weigand; Walter A Rocca; Rosebud O Roberts; Michelle M Mielke; Val J Lowe; David S Knopman; Vernon S Pankratz; Mary M Machulda; Yonas E Geda; Clifford R Jack Journal: JAMA Neurol Date: 2016-01 Impact factor: 18.302
Authors: Hsu-Ko Kuo; Richard N Jones; William P Milberg; Sharon Tennstedt; Laura Talbot; John N Morris; Lewis A Lipsitz Journal: J Am Geriatr Soc Date: 2006-01 Impact factor: 5.562
Authors: J Alex Becker; Trey Hedden; Jeremy Carmasin; Jacqueline Maye; Dorene M Rentz; Deepti Putcha; Bruce Fischl; Douglas N Greve; Gad A Marshall; Stephen Salloway; Donald Marks; Randy L Buckner; Reisa A Sperling; Keith A Johnson Journal: Ann Neurol Date: 2011-03-17 Impact factor: 10.422
Authors: Michael L Alosco; Jonathan Duskin; Lilah M Besser; Brett Martin; Christine E Chaisson; John Gunstad; Neil W Kowall; Ann C McKee; Robert A Stern; Yorghos Tripodis Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Tina E Brinkley; Iris Leng; Thomas C Register; Bryan J Neth; Henrik Zetterberg; Kaj Blennow; Suzanne Craft Journal: Front Neurosci Date: 2022-06-02 Impact factor: 5.152
Authors: Jordi Pegueroles; Adriana Pané; Eduard Vilaplana; Víctor Montal; Alexandre Bejanin; Laura Videla; María Carmona-Iragui; Isabel Barroeta; Ainitze Ibarzabal; Anna Casajoana; Daniel Alcolea; Silvia Valldeneu; Miren Altuna; Ana de Hollanda; Josep Vidal; Emilio Ortega; Ricardo Osorio; Antonio Convit; Rafael Blesa; Alberto Lleó; Juan Fortea; Amanda Jiménez Journal: Alzheimers Dement (Amst) Date: 2020-07-28
Authors: Jennifer S Rabin; Zahra Shirzadi; Walter Swardfager; Bradley J MacIntosh; Aaron Schultz; Hyun-Sik Yang; Rachel F Buckley; Jennifer R Gatchel; Dylan Kirn; Jeremy J Pruzin; Trey Hedden; Nir Lipsman; Dorene M Rentz; Sandra E Black; Keith A Johnson; Reisa A Sperling; Jasmeer P Chhatwal Journal: Neurobiol Aging Date: 2020-03-07 Impact factor: 4.673
Authors: Rachel M Shaffer; Ge Li; Sara D Adar; C Dirk Keene; Caitlin S Latimer; Paul K Crane; Eric B Larson; Joel D Kaufman; Marco Carone; Lianne Sheppard Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Seung Hoon Lee; Min Soo Byun; Jun Ho Lee; Dahyun Yi; Bo Kyung Sohn; Jun-Young Lee; Yu Kyeong Kim; Seong A Shin; Chul-Ho Sohn; Dong Young Lee Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Jee Wook Kim; Min Soo Byun; Dahyun Yi; Jun Ho Lee; Kang Ko; So Yeon Jeon; Bo Kyung Sohn; Jun-Young Lee; Yu Kyeong Kim; Seong A Shin; Chul-Ho Sohn; Dong Young Lee Journal: PLoS Med Date: 2020-02-25 Impact factor: 11.069